Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling
- PMID: 11226409
- DOI: 10.1016/s0014-5793(01)02166-4
Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling
Abstract
Previous studies have shown that certain tumor cell lines which naturally express high levels of the epidermal growth factor receptor (EGFR) undergo apoptosis when exposed to epidermal growth factor. Whether this phenomenon is a direct result of receptor overexpression or some other genetic alteration renders these cells sensitive to apoptosis is yet to be established. We show that experimentally increasing the level of EGFR expression predictably leads to apoptosis in a variety of cell types which requires an active tyrosine kinase but not EGFR autophosphorylation sites. Expression of a dominant negative Ras mutant in EGFR overexpressing cells results in a significant potentiation of EGFR induced apoptosis suggesting that Ras activation is a key survival signal generated by the EGFR. We propose that potentiation of EGFR induced apoptosis by dominant negative Ras results, at least in part, by a block of Akt activation.
Comment in
-
EGF receptor: which way to go?FEBS Lett. 2001 Feb 23;491(1-2):1-3. doi: 10.1016/s0014-5793(01)02163-9. FEBS Lett. 2001. PMID: 11226407 No abstract available.
Similar articles
-
Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells.J Biol Chem. 2002 Oct 11;277(41):38978-87. doi: 10.1074/jbc.M205002200. Epub 2002 Aug 7. J Biol Chem. 2002. PMID: 12167618
-
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.J Exp Clin Cancer Res. 2019 Jan 28;38(1):41. doi: 10.1186/s13046-019-1035-0. J Exp Clin Cancer Res. 2019. PMID: 30691487 Free PMC article.
-
Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.Mol Cancer Res. 2003 Jan;1(3):219-33. Mol Cancer Res. 2003. PMID: 12556561
-
Signaling inhibition with radiation in colorectal cancer: clinical trials.Semin Oncol. 2003 Jun;30(3 Suppl 6):56-67. doi: 10.1016/s0093-7754(03)00126-x. Semin Oncol. 2003. PMID: 12802796 Review.
-
The epidermal growth factor receptor and its ligands.Cancer Treat Res. 1989;47:143-68. doi: 10.1007/978-1-4613-1599-5_6. Cancer Treat Res. 1989. PMID: 2576995 Review. No abstract available.
Cited by
-
TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.PLoS One. 2012;7(10):e47184. doi: 10.1371/journal.pone.0047184. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071754 Free PMC article.
-
The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors.EMBO J. 2002 Apr 2;21(7):1684-94. doi: 10.1093/emboj/21.7.1684. EMBO J. 2002. PMID: 11927552 Free PMC article.
-
Epidermal growth factor preserves myelin and promotes astrogliosis after intraventricular hemorrhage.Glia. 2016 Nov;64(11):1987-2004. doi: 10.1002/glia.23037. Epub 2016 Jul 29. Glia. 2016. PMID: 27472419 Free PMC article.
-
Excess Transforming Growth Factor-α Changed the Cell Properties of Corneal Epithelium and Stroma.Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):20. doi: 10.1167/iovs.61.8.20. Invest Ophthalmol Vis Sci. 2020. PMID: 32668000 Free PMC article.
-
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling.Oncotarget. 2017 Feb 14;8(7):12194-12202. doi: 10.18632/oncotarget.14577. Oncotarget. 2017. PMID: 28086240 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
